These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6800057)

  • 21. Pulmonary embolism.
    Unger KM
    Am Fam Physician; 1982 Oct; 26(4):189-98. PubMed ID: 7124579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency.
    Zucker ML; Gomperts ED; Marcus RG
    S Afr Med J; 1976 Oct; 50(43):1743-8. PubMed ID: 63150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Strategies for utilization of anticoagulants in pulmonary embolism].
    Fartoukh M; Simonneau G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic therapy for venous thromboembolism.
    Hyers TM
    Clin Chest Med; 1984 Sep; 5(3):479-86. PubMed ID: 6386292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin therapy - Part II.
    Caprini JA; Zoellner JL; Weisman M
    Cardiovasc Nurs; 1977; 13(4):17-20. PubMed ID: 586158
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of venous thromboembolic disease. A pragmatic approach to anticoagulation and thrombolysis.
    Linn BJ; Mazza JJ; Friedenberg WR
    Postgrad Med; 1986 May; 79(6):171-80. PubMed ID: 3703754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.
    Laufman H
    Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618
    [No Abstract]   [Full Text] [Related]  

  • 29. Decreased antithrombin III level associated with failure of anticoagulation.
    Hanna W; Chen J; Hanna S
    South Med J; 1982 Apr; 75(4):500-1. PubMed ID: 7071651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin kinetics in venous thrombosis and pulmonary embolism.
    Hirsh J; van Aken WG; Gallus AS; Dollery CT; Cade JF; Yung WL
    Circulation; 1976 Apr; 53(4):691-5. PubMed ID: 1253392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of heparin requirements in acute thromboplastic venous disease.
    Beaver BL; Young D; Satiani B
    Arch Surg; 1985 Apr; 120(4):436-8. PubMed ID: 3985788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulants: a guide for practitioners.
    Kingdon HS
    Postgrad Med; 1973 Jul; 54(1):88-92 contd. PubMed ID: 4714263
    [No Abstract]   [Full Text] [Related]  

  • 33. New perspectives for treatment of pulmonary embolism.
    Simonneau G
    Haemostasis; 1998; 28 Suppl 3():95-9. PubMed ID: 10069768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anticoagulated patient in labor: an obstetric dilemma.
    Knuppel RA; Petrucha RA
    South Med J; 1981 Sep; 74(9):1084-7. PubMed ID: 7280756
    [No Abstract]   [Full Text] [Related]  

  • 35. Thromboembolic complications during anticoagulant therapy.
    Coon WW; Willis PW
    Arch Surg; 1972 Aug; 105(2):209-12. PubMed ID: 5044547
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intrapulmonary heparin].
    Huang SW
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Dec; 11(6):370-2. PubMed ID: 3074878
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of pulmonary embolism. I. Treatment with heparin and oral anticoagulants].
    Niewiarowski T; Filipecki S
    Pneumonol Pol; 1984 Sep; 52(9):447-52. PubMed ID: 6085154
    [No Abstract]   [Full Text] [Related]  

  • 38. Continuous heparin infusion requirements. Diagnostic and therapeutic implications.
    White TM; Bernene JL; Marino AM
    JAMA; 1979 Jun; 241(25):2717-20. PubMed ID: 448818
    [No Abstract]   [Full Text] [Related]  

  • 39. Empiric use of anticoagulant and fibrinolytic agents in surgery.
    Laufman H
    Thromb Diath Haemorrh Suppl; 1973; 56():265-73. PubMed ID: 4549137
    [No Abstract]   [Full Text] [Related]  

  • 40. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.